New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
07:24 EDTCVSCVS Caremark price target raised to $84-$89 from $75-$80 at Wells Fargo
Wells Fargo increased its price target on CVS as the firm is more confident in the company's near-term and five-year financial targets following recent developments involving the company. Wells thinks that the stock is undervalued at current levels and keeps an Outperform rating on the shares.
News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
08:31 EDTCVSCVS Caremark's Accordant Health receives NCQA accreditation
CVS Caremark announced that its Accordant Health Services division has received full NCQA Patient and Practitioner Oriented Disease Management accreditation for programs to support: Epilepsy, Rheumatoid Arthritis, Multiple Sclerosis, Crohn's Disease, Ulcerative Colitis, Parkinson's Disease, Systemic Lupus Erythematosus, Myasthenia Gravis, Sickle Cell Disease, Cystic Fibrosis, Hemophilia, Scleroderma, Polymyositis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Amyotrophic Lateral Sclerosis, Dermatomyositis, and Gaucher Disease.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use